Clinical Trial Update: Feasibility Study of the FARAFLEX Mapping and PFA System [NA]

View source ↗

Summary

This update reports a feasibility study of the FARAFLEX Mapping and PFA System by Boston Scientific for atrial fibrillation. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation, Persistent Atrial Fibrillation | NA | Status: RECRUITING